Cargando…
Arterial events, venous thromboembolism, thrombocytopenia, and bleeding after vaccination with Oxford-AstraZeneca ChAdOx1-S in Denmark and Norway: population based cohort study
OBJECTIVE: To assess rates of cardiovascular and haemostatic events in the first 28 days after vaccination with the Oxford-AstraZeneca vaccine ChAdOx1-S in Denmark and Norway and to compare them with rates observed in the general populations. DESIGN: Population based cohort study. SETTING: Nationwid...
Autores principales: | Pottegård, Anton, Lund, Lars Christian, Karlstad, Øystein, Dahl, Jesper, Andersen, Morten, Hallas, Jesper, Lidegaard, Øjvind, Tapia, German, Gulseth, Hanne Løvdal, Ruiz, Paz Lopez-Doriga, Watle, Sara Viksmoen, Mikkelsen, Anders Pretzmann, Pedersen, Lars, Sørensen, Henrik Toft, Thomsen, Reimar Wernich, Hviid, Anders |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group Ltd.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8097496/ https://www.ncbi.nlm.nih.gov/pubmed/33952445 http://dx.doi.org/10.1136/bmj.n1114 |
Ejemplares similares
-
Thromboembolism and the Oxford–AstraZeneca COVID-19 vaccine: side-effect or coincidence?
por: Østergaard, Søren Dinesen, et al.
Publicado: (2021) -
Immune thrombocytopenia following immunisation with Vaxzevria ChadOx1-S (AstraZeneca) vaccine, Victoria, Australia
por: Gordon, Sally F., et al.
Publicado: (2021) -
Impact of Improper Storage of ChAdOx1-S (AstraZeneca) Vaccine on Its Efficacy and Safety
por: Mikołajczyk, Marek, et al.
Publicado: (2022) -
AstraZeneca COVID-19 vaccine: thrombosis with thrombocytopenia
Publicado: (2021) -
Anaphylaxis in Australia with AstraZeneca's COVID-19 vaccine
Publicado: (2021)